Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

China SXT Pharmaceuticals (SXTC) Inventory Average: 2018-2025

  • China SXT Pharmaceuticals' Inventory Average fell 4.98% to $789,700 in Q3 2025 from the same period last year, while for Sep 2025 it was $789,700, marking a year-over-year decrease of 4.98%. This contributed to the annual value of $811,454 for FY2025, which is 22.38% up from last year.
  • China SXT Pharmaceuticals' Inventory Average amounted to $789,700 in Q3 2025, which was down 6.84% from $847,643 recorded in Q1 2025.
  • China SXT Pharmaceuticals' 5-year Inventory Average high stood at $927,487 for Q1 2022, and its period low was $512,234 during Q3 2023.
  • For the 3-year period, China SXT Pharmaceuticals' Inventory Average averaged around $700,729, with its median value being $716,867 (2024).
  • As far as peak fluctuations go, China SXT Pharmaceuticals' Inventory Average tumbled by 37.75% in 2023, and later spiked by 62.24% in 2024.
  • China SXT Pharmaceuticals' Inventory Average (Quarterly) stood at $848,572 in 2021, then dropped by 3.03% to $822,856 in 2022, then tumbled by 37.75% to $512,234 in 2023, then soared by 62.24% to $831,044 in 2024, then decreased by 4.98% to $789,700 in 2025.
  • Its Inventory Average stands at $789,700 for Q3 2025, versus $847,643 for Q1 2025 and $831,044 for Q3 2024.